← New search
Phenotype profile

multiple sclerosis

SaudiVarKB evidence summary derived from retained literature mentions.

195Phenotype mentions
100Publications
50Associated gene records
37Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
HLA-DRB1HGNC:494855
MBPHGNC:692544
CD4HGNC:167833
BDNFHGNC:103333
IRF4HGNC:611922
MT-ND4HGNC:745922
CD19HGNC:163322
CD14HGNC:162822
PARP1HGNC:27011
TNFHGNC:1189211
STAT6HGNC:1136811
SOD1HGNC:1117911
IL2RAHGNC:600811
AQP4HGNC:63711
LIPAHGNC:661711
STAT4HGNC:1136511
IL10HGNC:596211
CDC42HGNC:173611
LRRK2HGNC:1861811
PINK1HGNC:1458111
MECP2HGNC:699011
CNPHGNC:215811
SYNE1HGNC:1708911
AKT1HGNC:39111
MALAT1HGNC:2966511
PTPN22HGNC:965211
VDRHGNC:1267911
SOX5HGNC:1120111
CYP27B1HGNC:260611
HLA-DQB1HGNC:494411
CNTFHGNC:216911
CD44HGNC:168111
HTRA1HGNC:947611
IL1BHGNC:599211
RAC2HGNC:980211
GALCHGNC:411511
RPL5HGNC:1036011
GATA3HGNC:417211
NGFHGNC:780811
NFKB1HGNC:779411
OPA1HGNC:814011
OPA3HGNC:814211
OASLHGNC:809011
DOCK4HGNC:1919211
SNAP25HGNC:1113211
HLA-DQA1HGNC:494211
IRF5HGNC:612011
THRILHGNC:4950311
RPL9HGNC:1036911
AXLHGNC:90511

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
m.14484T>Cm.14484T>C22
m.11778G>Am.11778G>A11
m.11778G>Am.11778G>A11
m.3460G>Am.3460G>A11
m.10237T>Cm.10237T>C11
m.9101T>Cm.9101T>C11
rs7975232rs797523211
rs1544410rs154441011
rs731236rs73123611
rs2228570rs222857011
rs2476601rs247660111
rs3135388rs313538811
p.R389Hp.R389H11
rs118204009rs11820400911
c.1156C>Tc.1156C>T11
rs1971676214rs197167621411
D173ED173E11
rs1242552448rs124255244811
D173HD173H11
rs772570115rs77257011511
G176WG176W11
m.12308A>Gm.12308A>G11
m.11467A>Gm.11467A>G11
m.12372G>Am.12372G>A11
10237T>C10237T>C11
15884G>C15884G>C11
9288A>G9288A>G11
14484T>C14484T>C11
15431G>A15431G>A11
8490T>C8490T>C11
5437C>T5437C>T11
rs6604026rs660402611
m.11150G>Am.11150G>A11
m.11519A>Cm.11519A>C11
m.11523A>Cm.11523A>C11
m.11527C>Tm.11527C>T11
rs71624119rs7162411911

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia1111
Saudi ArabiaCohort 4733
Population recordCohort 50111
Saudi Arabia11
Population record11
Population recordCohort 31711
Population recordCohort 1011
Population recordCohort 1811
Population recordCohort 2311
Saudi Arabia · Riyadh11
Saudi ArabiaCohort 211
Population recordCohort 10411
Population recordCohort 10011
Population recordCohort 2811
Population recordCohort 1511
Population recordCohort 3311
Population recordCohort 6011
Saudi ArabiaCohort 10011
Saudi ArabiaCohort 3211
Population recordCohort 23611
Saudi ArabiaCohort 16911
Population recordCohort 5511
Saudi Arabia · RiyadhCohort 5011
Population recordCohort 3511
Population recordCohort 12411
Population recordCohort 10111
Saudi Arabia · Eastern Province11
Population recordCohort 69011
Saudi Arabia · RiyadhCohort 1111
Population recordCohort 20311
Saudi ArabiaCohort 38411
Saudi ArabiaCohort 37011
Population recordCohort 14811
Saudi Arabia · Medina11
Population recordCohort 19711
Population recordCohort 43011
Saudi Arabia · Eastern ProvinceCohort 2,02311
Saudi ArabiaCohort 42811
Population recordCohort 1,00011
Saudi Arabia · JeddahCohort 60211
Population recordCohort 69911
Population recordCohort 81011
Population recordCohort 8,74111
Saudi ArabiaCohort 35611
Saudi Arabia · JeddahCohort 34111
Saudi Arabia · Madinah11
Saudi ArabiaCohort 15511
Saudi Arabia · RiyadhCohort 30011
Saudi ArabiaCohort 8211
Saudi ArabiaCohort 2,51611

Supporting publications

100 records
  1. 2026The gut-brain axis: role of gut microbiota in neurological disease pathogenesis and pharmacotherapeutics.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  2. 2026Unraveling the metabolic potential of Moringa oleifera derived metabolites in combating Parkinson's and Alzheimer's disease.Bioorganic chemistry1 mentions
  3. 2026Built-environment correlates of physical activity in youth with multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England)1 mentions
  4. 2026Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity and inclusion: A modified e-Delphi study.Multiple sclerosis journal - experimental, translational and clinical1 mentions
  5. 2026Causal association between multiple sclerosis and trigeminal neuralgia: A Mendelian randomization study with meta-analysis.Cranio : the journal of craniomandibular practice1 mentions
  6. 2026Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Journal of neurology1 mentions
  7. 2026Modulating the Gut Microbiome as a Therapeutic Approach in Multiple Sclerosis: Implications for Gut-Brain Interactions and Immune Pathways: A Narrative Review.Brain and behavior1 mentions
  8. 2026Adenosine A₂A receptor as a dual-acting molecular switch: Glial morphological changes and neurovascular tissue remodeling in neuroinflammation and neurodegeneration.Tissue & cell1 mentions
  9. 2026An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis.Pharmaceuticals (Basel, Switzerland)1 mentions
  10. 2026Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosis.Multiple sclerosis and related disorders1 mentions
  11. 2026Prevalence and predictive factors of epilepsy in multiple sclerosis: A cross-sectional study from Saudi Arabia.Multiple sclerosis and related disorders1 mentions
  12. 2026Identifying strategies to characterize the diversity of the MS population in Canada: a nominal group study.Frontiers in neurology1 mentions
  13. 2026Decoding the genetic basis of demyelination: Prediction of potential pathogenic coding and regulatory noncoding MBP SNPs in multiple sclerosis.PloS one1 mentions
  14. 2026Viral associations in multiple sclerosis: pathogenetic mechanisms and therapeutic implications.Virology journal1 mentions
  15. 2026Analysis of the comprehension and familiarity among the Saudi Arabian population regarding multiple sclerosis.Journal of family medicine and primary care1 mentions
  16. 2026Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia.Progress in neuro-psychopharmacology & biological psychiatry1 mentions
  17. 2026The many faces of the multiple sclerosis population in Canada.Multiple sclerosis and related disorders1 mentions
  18. 2026Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.Multiple sclerosis and related disorders1 mentions
  19. 2026Clinical Characteristics of Multiple Sclerosis and Association of MS Severity with Vitamin D Level in the Madinah Region of Saudi Arabia: A Cross-Sectional Study.Neurosciences (Riyadh, Saudi Arabia)1 mentions
  20. 2026Obesity and Risk of Pediatric-Onset Multiple Sclerosis (POMS): a Systematic Review and Meta-Analysis.Maedica1 mentions
  21. 2025Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?Paediatric drugs1 mentions
  22. 2025Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c-Jun Pathway.Drug development research1 mentions
  23. 2025Abnormality of Voltage-Gated Sodium Channels in Disease Development of the Nervous System. A Review Article.CNS & neurological disorders drug targets1 mentions
  24. 2025Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management.Frontiers in chemistry1 mentions
  25. 2025Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials.Frontiers in pharmacology1 mentions
  26. 2025Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.Frontiers in pharmacology1 mentions
  27. 2025Associations between fronto-limbic white matter connections and internalizing symptoms in pediatric demyelinating disease.Multiple sclerosis and related disorders1 mentions
  28. 2025Glucose metabolism is controlled by non-coding RNAs in autoimmune diseases; a glimpse into immune system dysregulation.Human immunology1 mentions
  29. 2025Mitochondrial Uncoupler, 2,4-Dinitrophenol, Reduces Spinal Cord Paralysis and Retinal Ganglion Cell Loss in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Biomolecules1 mentions
  30. 2025Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review.Multiple sclerosis journal - experimental, translational and clinical1 mentions
  31. 2025Nano-healing: Exploring the Therapeutic Potentials of Nanomedicine for CNS Disorders.Current pharmaceutical design1 mentions
  32. 2025Cyclophosphamide as initial treatment of aggressive MS (Marburg variant) in resource limited settings - A case report.Clinical neurology and neurosurgery1 mentions
  33. 2025Emphasizing complementary in "Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis".Multiple sclerosis (Houndmills, Basingstoke, England)1 mentions
  34. 2025Environmental and Familial Risk Factors for Multiple Sclerosis: Insights from a Saudi Arabian Cohort.Medicina (Kaunas, Lithuania)1 mentions
  35. 2025The janus face of astrocytes in multiple sclerosis: Balancing protection and pathology.Brain research bulletin1 mentions
  36. 2025Physical activity demonstrates protective associations with structural visual metrics in children with multiple sclerosis through time.Multiple sclerosis (Houndmills, Basingstoke, England)1 mentions
  37. 2025Cannabidiol as an immune modulator: A comprehensive review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  38. 2025Clinical profile of seizures among multiple sclerosis patients in a tertiary care center.Multiple sclerosis and related disorders1 mentions
  39. 2025A Patient with Marburg's Variant of Multiple Sclerosis Responded Well to Cyclophosphamide.Annals of African medicine1 mentions
  40. 2025Potential therapeutic effects of ibudilast and retinoic acid against cuprizone-induced behavioral and biochemical changes in mouse brain.Frontiers in molecular neuroscience1 mentions
  41. 2025Unraveling the Role of THRIL/miR-137 in Fine-Tuning the Immunological Transcriptional Loop STAT4/STAT6/GATA3 in Multiple Sclerosis: Implications on Neurological Complications and Disease Subtypes.ACS chemical neuroscience1 mentions
  42. 2025Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions.Multiple sclerosis and related disorders1 mentions
  43. 2025Dysregulation and gene polymorphisms of Vitamin D receptor: its implications in lipid metabolic disorders.Molecular biology reports1 mentions
  44. 2025Outcome of two siblings with late-onset Krabbe disease following allogeneic hematopoietic stem cell transplantation: And review of literature.Molecular genetics and metabolism reports1 mentions
  45. 2025From Molecules to Medicines: The Role of AI-Driven Drug Discovery Against Alzheimer's Disease and Other Neurological Disorders.Pharmaceuticals (Basel, Switzerland)1 mentions
  46. 2025Access to therapy for children and adolescents with multiple sclerosis: global considerations in preventing disease progression.The Lancet. Child & adolescent health1 mentions
  47. 2025The Microbiota-Gut-Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders.CNS neuroscience & therapeutics1 mentions
  48. 2025Impact of the CYP27B1 p.R389H mutation on protein stability and function: implications for multiple sclerosis pathogenesis.Scientific reports1 mentions
  49. 2025IVIM-DWI-Based Radiomics for Lesion Phenotyping and Clinical Status Prediction in Relapsing-Remitting Multiple Sclerosis.Journal of clinical medicine1 mentions
  50. 2025A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors.Multiple sclerosis and related disorders1 mentions
  51. 2025A comprehensive overview of the effects of probiotics, prebiotics and synbiotics on the gut-brain axis.Frontiers in microbiology1 mentions
  52. 2025Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers.Inflammopharmacology1 mentions
  53. 2025Exploring the role of genetic variants in susceptibility to autoimmune Diseases: A molecular genetics approach.Human immunology1 mentions
  54. 2025Exploring the Neuroprotective Role of the Sulfonamide Derivative KM11 in Ethidium Bromide-induced Demyelination in Zebrafish Model Through Modulation of Antioxidant and Inflammatory Cytokine Pathways.Molecular neurobiology1 mentions
  55. 2025Mitochondrial-Immune Overlap in Leber Hereditary Optic Neuropathy: A Case Report and Lessons Learned.Reports (MDPI)1 mentions
  56. 2024Neuro-Behcet's disease misdiagnosed and treated as multiple sclerosis: a deceiving masquerader.The International journal of neuroscience1 mentions
  57. 2024Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset.Annals of clinical and translational neurology1 mentions
  58. 2024Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1.Pathology, research and practice1 mentions
  59. 2024Potential clinical implications of molecular mimicry-induced autoimmunity.Immunity, inflammation and disease1 mentions
  60. 2024The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis.Neuromolecular medicine1 mentions
  61. 2024Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.Cytokine1 mentions
  62. 2024Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders.Frontiers in bioscience (Landmark edition)1 mentions
  63. 2024An Uncommon Coexistence of Ischemic Stroke in a Multiple Sclerosis Patient With Duplicated Superior Cerebellar Artery: A Case Report From Saudi Arabia.Cureus1 mentions
  64. 2024Tepilamide Fumarate as a Novel Potentiator of Virus-Based Therapy.Viruses1 mentions
  65. 2024Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits.Ageing research reviews1 mentions
  66. 2024Tumefactive demyelinating lesions: A literature review of recent findings.Neurosciences (Riyadh, Saudi Arabia)1 mentions
  67. 2024FTY720 Reduces the Biomass of Biofilms in Pseudomonas aeruginosa in a Dose-Dependent Manner.Antibiotics (Basel, Switzerland)1 mentions
  68. 2024A Comprehensive Review of Leber Hereditary Optic Neuropathy and Its Association with Multiple Sclerosis-Like Phenotypes Known as Harding's Disease.Eye and brain1 mentions
  69. 2024circRNAs as Epigenetic Regulators of Integrity in Blood-Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis.Cells1 mentions
  70. 2024Multiple sclerosis and amyotrophic lateral sclerosis: is there an association or a red flag? A case report and literature review.BMC neurology1 mentions
  71. 2024Social network characteristics and their relationships with physical activity in children with multiple sclerosis.Multiple sclerosis and related disorders1 mentions
  72. 2024Interplays Between Matrix Metalloproteinases and Neurotropic Viruses: An Overview.Reviews in medical virology1 mentions
  73. 2024Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis.Neurology(R) neuroimmunology & neuroinflammation1 mentions
  74. 2024Establishing consensus on lifestyle recommendations and behaviour change strategies to promote brain health-focussed care for multiple sclerosis: A modified e-Delphi study.Multiple sclerosis and related disorders1 mentions
  75. 2024Need for neurorehabilitation in the Middle East and North Africa from 1990 to 2021: an analysis based on the global burden of disease study.Annals of medicine and surgery (2012)1 mentions
  76. 2024Management and outcomes of pediatric optic neuritis in a tertiary hospital in Riyadh, Saudi Arabia: a retrospective study.BMC neurology1 mentions
  77. 2024Corneal Confocal Microscopy Identifies and Differentiates Patients With Multiple Sclerosis and Epilepsy.Translational vision science & technology1 mentions
  78. 2024Neurotherapeutic impact of vanillic acid and ibudilast on the cuprizone model of multiple sclerosis.Frontiers in molecular neuroscience1 mentions
  79. 2023Diagnosis and treatment of progressive multiple sclerosis: A position paper.European journal of neurology1 mentions
  80. 2023CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.Human genetics1 mentions
  81. 2023Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England)1 mentions
  82. 2023Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.European journal of neurology1 mentions
  83. 2023Experience and perception of utilizing virtual clinic in neurological assessment in Saudi Arabia.Frontiers in neurology1 mentions
  84. 2023Online Health Information Seeking by Individuals With Physical Disabilities Caused by Neurological Conditions in Saudi Arabia.Cureus1 mentions
  85. 2023Probiotic-Fermented Camel Milk Attenuates Neurodegenerative Symptoms via SOX5/miR-218 Axis Orchestration in Mouse Models.Pharmaceuticals (Basel, Switzerland)1 mentions
  86. 2023Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie1 mentions
  87. 2023Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model.Brain communications1 mentions
  88. 2023Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): A challenging diagnosis and a rare multiple sclerosis mimic.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association1 mentions
  89. 2023The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles.International immunopharmacology1 mentions
  90. 2023Medication Adherence Status and Its Association With Quality of Life Among Individuals With Neurological Conditions in Saudi Arabia.Cureus1 mentions
  91. 2023The small molecule Erk1/2 signaling pathway inhibitor PD98059 improves DNA repair in an experimental autoimmune encephalomyelitis SJL/J mouse model of multiple sclerosis.Mutation research. Genetic toxicology and environmental mutagenesis1 mentions
  92. 2023Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases.Pathology, research and practice1 mentions
  93. 2023Multiple Sclerosis-A Demyelinating Disorder and Its Dental Considerations-A Literature Review with Own Case Report.Brain sciences1 mentions
  94. 2023The protective effects of sesamol and/or the probiotic, Lactobacillus rhamnosus, against aluminum chloride-induced neurotoxicity and hepatotoxicity in rats: Modulation of Wnt/β-catenin/GSK-3β, JAK-2/STAT-3, PPAR-γ, inflammatory, and apoptotic pathways.Frontiers in pharmacology1 mentions
  95. 2023Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities.Biomolecules1 mentions
  96. 2023DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.International journal of molecular sciences1 mentions
  97. 2023The microRNAs (miRs) overexpressing mesenchymal stem cells (MSCs) therapy in neurological disorders; hope or hype.Biotechnology progress1 mentions
  98. 2023Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study.Neurology1 mentions
  99. 2023Metabolite Alterations in Autoimmune Diseases: A Systematic Review of Metabolomics Studies.Metabolites1 mentions
  100. 2023Sleep, physical activity, and psychological outcomes in children and adolescents with pediatric onset multiple sclerosis.Multiple sclerosis and related disorders1 mentions